We reported one case of human immunodeficiency virus and hepatitis C virus co-infected patient who presented a significant improvement of human papillomavirus (HPV) lesions during the treatment of chronic hepatitis using peg-interferon alfa-2b and ribavirin.
A human immunodeficiency virus (HIV) and hepatitis C virus (HCV) co-infected patient using zidovudine, lamivudine and efavirenz presented, since 1999, multiple human papillomavirus (HPV) lesions (which diagnosis was made clinically and by histologic examination ) in the genital tract, anal, lumbar, and cervical regions, on the left hand, nose, as well as extensive lesions on the right foot ( Figure 1 ) with bad evolution after numerous therapies (cryotherapy with liquid nitrogen, trichloroacetic acid, nitric acid, 5-fluorouracil, shaving, podophyllin resin, phytotherapies, ozone and topic BCG).
During the treatment for chronic HCV infection with peginterferon alfa-2b and ribavirin (started in April 2006 ) the patient showed a complete and fast disappearance of face and hand lesions, in addition to a significant and progressive improvement on the right foot lesions (Figure 2 ) in spite of the decrease of CD4-cell count that occurred during the interferon use. There is a report on the use of peg-interferon alfa-2b associated with acitretin (3) in a woman presenting epidermodisplasia verruciformis with multiple mucosal carcinomas. After one year of treatment, there was a significant improvement of verrucous lesions and no recurrence of mucosal cancer.
The improvement of HPV lesions using peg-Interferon alfa-2b and ribavirin during the treatment of chronic HCV infection shows that this association can be of great value for cases that present more resistance to the conventional therapy. BJID 2007; 11 (June) Figure 2. Right foot without lesions seven months after treatment with peg-interferon alfa-2b and ribavirin.
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